Out of patients responded to initial therapy with that treatment regimen and all patients had full or partial reduction of their tumors later after radiation treatment said dr. In a preliminary study patients with potentially operable tumors completed treatment with radiation and the drugs gemcitabine and bevacizumab. The study funded by pfizer has since moved into its next stage where it will enroll more patients. The overall response rate was percent. A. Dr.